Multiple Sclerosis Research FAQs Contact
Myelin Repair Foundation — Collaboration. Acceleration. Results.
Home About Us Research Model Myelin Repair News Join Us Donate
The Myelin Repair Foundation is speeding the time it takes to discover, develop  and deliver treatments to multiple sclerosis patients who simply can't afford to wait. NERVE AXON WITH MYELIN PROTECTIVE COATING
A New Model Offering New Hope Repairing damaged myelin will reduce the symptoms of MS. What MRF scientists are learning about myelin biology is advancing research for all neurological diseases.
Learn more about our accelerated research model: Launch Video!
Research and News Updates

August 15, 2008

Paths to Progress: MS Focus Magazine features MRF update on myelin repair research.

biotechTransfer week: Myelin Repair Foundation Taps CDD Software To Support ‘Accelerated’ Academic Research

John Hagel and John Seely Brown review MRF’s ARC model in BusinessWeek’s Innovation on the Edge.

Non-Profit Gears Up for Biotech Roadshow
San Francisco Chronicle – March 29, 2008

“Johnson (MRF) has duplicated the collaborative environment Genentech and other science-driven companies try to create for their in-house researchers. Genentech wouldn't hesitate to hear proposals from the nonprofit.” —Hal Barron, Senior Vice President of Development, Genentech

MRF Names Six Senior Pharma Execs to Drug Discovery Advisory Group (DDAG). The DDAG is tasked with evaluating and prioritizing MRF’s therapeutic targets for myelin repair. Their input in the development of industry-competitive data packages will be central to speeding MRF’s drug discovery and development efforts. More…

Watch Our Progress

Video

How the MRF is speeding the clinical development of patient treatments. (Duration 6:50)

Video

Five approaches to myelin repair. (Duration: 8:16)

 

Download a PDF version of the MRF brochure here.

 

 

President's Message

August 11, 2008

Photo: Scott JohnsonThe ARC Model and Peer Review

When we launched our myelin repair research program four years ago, we developed a rigorous peer review process to ensure that the science conducted in our funded laboratories was of the highest quality, and that all experiments in the program would lead us on the path of achieving (1) our interim goal of licensing a myelin repair therapeutic target for commercial drug development within five years and (2) our ultimate goal of making effective myelin repair treatments available to MS patients.

Read more...

Multiple Sclerosis Research

The objective of our multiple sclerosis research is to gain a deeper understanding of the natural process of myelination and how multiple sclerosis disrupts it. Through our research we are identifying therapeutic targets that may restore the myelination process and effectively remyelinate previously damaged areas in multiple sclerosis patients. Read more about our multiple sclerosis research. Register to receive research updates.

You Can Make a Difference

MRF depends on the support of individuals like you as well as corporations and foundations, including the Robert Wood Johnson Foundation, Omidyar Network and Biogen Idec, to name a few.

Donate now to myelin repair research and MRF's accelerated research model.

1-877-ToFixMS (1-877-863-4967)

 

Overview
President's Message
Vision and Mission
Management Team
Principal Investigators
Board and Advisors
FAQs
Contact Us
Overview
Accelerated Research Collaboration (ARC™)
ARC™ vs. Traditional Research
Overview
Research Results
Research Plan
Publications
Principal Investigators
Scientific Advisory Board
Newsroom and Resources
New Archive
Research Report Archive
White Papers Archive
Overview
Register
Tell a Friend
Ways to Donate
Tell a Friend